Adial Pharmaceuticals Inc. logo

Adial Pharmaceuticals Inc. (ADIL)

Market Open
12 Jun, 15:11
NASDAQ (CM) NASDAQ (CM)
$
3. 07
+0.09
+3.0201%
$
2.32M Market Cap
- P/E Ratio
- Div Yield
515,594 Volume
-4.8 Eps
$ 2.98
Previous Close
Investors:
Add Transaction
Day Range
2.52 3.14
Year Range
1.31 19
Want to track ADIL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 49.4% in April

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 49.4% in April

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL - Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 49,013 shares, a decrease of 49.4% from the March 31st total of 96,887 shares. Currently, 3.5% of the company's stock are short sold.

Defenseworld | 1 month ago
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why

Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why

Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know

Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know

Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Glen Allen, VA, October 23, 2024 – PRISM MediaWire – Adial Pharmaceuticals, Inc.

Prismmediawire | 1 year ago
Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?

Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?

Adial Pharmaceuticals (NASDAQ:ADIL) stock is rocketing higher on Tuesday after the clinical-stage biopharmaceutical company announced an update on its AD04 study. Adial Pharmaceuticals notes that AD04 is progressing to a second cohort in its pharmacokinetics study.

Investorplace | 1 year ago
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025

Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025

Making millions through the stock market is only possible in a few ways. Investors need one of these three things: Massive sums of capital to begin with Decades of time and more modest sums of capital More modest sums of capital and a combination of risk and luck We will be talking about the latter today: seven stocks you can buy for $2 that can 10X by 2025.

Investorplace | 2 years ago